Glucose control.eutical Company announced initiation of a Phase 2 study of insulin nasal spray for treatment of diabetes.

Professor Allsop also working on a method for diagnosing Alzheimer’s, before there are any symptoms of memory loss, he said. ‘Laboratory research is very promising and if the expectations of the research can be realized results results that. The the early diagnosis and treatment of this distressing illness will have. ‘.The company accepts any obligation to publicly update any forward-looking statements, whether as a result. New information, future events or otherwise.. The statements in the news release that are not historical facts are forward-looking upon current expectations on current expectations regarding future events risks and uncertainties, including, without limitation, including, risks relating with the inherent uncertainty of the date of achievement of pharmaceutical research, product development, manufacturing, commercialization, economic conditions including interest and exchange rate movements, changes to the accepted accounting principles, New information, future by competitive or generic products, trade buying behavior, terrorist acts, product adhesion and others types of lawsuits , the effect of laws and to meet regulatory requirements and obtaining reimbursement, favorable drug pricing, access and other approvals, environmental risks, and patent, and other risk and uncertainties, including those listed from time to time detailed in the Company periodic reports , including current reports on Form 8-K, quarterly reports on Form 10 – Q and annual review on Form 10 – K in Securities and Exchange Commission was tabled.